SMS PHARMACEUTICALS LTD. - 532815 - Intimation Of Schedule Of Analyst / Institutional Investor Meetings Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. SMS Pharmaceuticals Ltd - 532815 - EVENT CALENDAR RELATED TO THE 33Rd ANNUAL GENERAL MEETING.
With reference to the above cited subject, we would like to bring to the notice of all the stakeholders the event calendar related to the 33rd Annual General Meeting (AGM) of the Company to be held on Thursday, September 30, 2021 through Video Conferencing/ OAVM: SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Credit Rating
Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015- Improved External Bank Loan Rating of SMS Pharmaceuticals Limited (SMS Pharma) We hereby inform that M/s CARE Ratings Limited has improved credit ratings on various facilities of the Company, the details are hereunder: ? Long Term Bank Facilities improved to 'CARE A; Stable (Single A; Outlook Stable)' from CARE A-; Stable (Single A Minus; Outlook Stable) ? Short Term Bank Facilities improved to 'CARE A2+; (A Two Plus)' from CARE A2; (A Two) SMS PHARMACEUTICALS LTD. - 532815 - Communication On Tax Deduction At Source ('TDS') On Dividend Payout.
With reference to the above cited subject, the Company is sending Notices to the shareholders who have registered their email ID's with the Company / Depository, regarding the Communication on Tax deduction at source ('TDS') on dividend payout for the FY 2020-21. as on dated 27th August, 2021, to all the shareholders. Further, the aforesaid communication is available in the website of the Company at https://smspharma.com/investor-relations/corporate-announcements/ for the convenience of the Shareholders. SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that the share certificates as per details given below are reported to have been lost / misplaced and request from shareholder is received by the Company through its Registrar and Share Transfer Agent M/s Aarthi consultants Private Limited for issue of duplicate share certificate(s) in lieu thereof. SMS Pharmaceuticals Ltd - 532815 - Intimation For Loss Of Share Certificates As Per Regulation 39(3) Of The SEBI(LODR) Regulations, 2015.
Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that the share certificates as per details given below are reported to have been lost / misplaced and request from shareholder is received by the Company through its Registrar and Share Transfer Agent M/s Aarthi consultants Private Limited for issue of duplicate share certificate(s) in lieu thereof. SMS Pharmaceuticals Ltd - 532815 - Intimation Of Schedule Of Analyst / Institutional Investor Meetings Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015.
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) SMS Pharmaceuticals Ltd - 532815 - Intimation Of Schedule Of Analyst / Institutional Investor Meetings Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015.
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) SMS PHARMACEUTICALS LTD. - 532815 - Please Find Attached The Press Release On The Financial Results For The Quarter Ended June 30, 2021.
Please find attached the press release on the Financial Results for the quarter ended June 30, 2021. Kindly take the same on record.
